Displaying results 1 - 10 / 105
results / page
What publication information is included in the service?
Publication name
Authors
Publication channel
Year
Publications information icon

Small-molecule screening assay for mono-adp-ribosyltransferases

Peer-reviewed
Open access
DOI
10.1007/978-1-4939-8588-3_16
Haikarainen, Teemu; Murthy, Sudarshan; Maksimainen, Mirko; Lehtiö, Lari
Methods in molecular biology2018Publications information icon

ADP-ribosylation in DNA repair – structural studies of human ADP-ribosyltransferase 2

Obaji, Ezeogo Ogbonnaya
Faculty of biochemisty and molecular medicine2018Publications information icon

The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling

Peer-reviewed
Open access
DOI
10.1016/j.jbc.2021.101041
Russo, Lilian Cristina; Tomasin, Rebeka; Matos, Isaac Araújo; Manucci, Antonio Carlos; Sowa, Sven T....
Journal of biological chemistry2021Publications information icon

Biochemical and structural studies of E3 ubiquitin ligase DTX3L : a protein at a crossroads of ubiquitination and ADP-ribosylation

Vela Rodríguez, Carlos
Faculty of biochemisty and molecular medicine2023Publications information icon

Inhibition of the Poly-ADP-Ribosylation activity of Tankyrases: Role in obesity, diabetes, and kidney injury

Open access
Kuusela, Sara L. M.
Helsingin yliopisto2021Publications information icon

ADP-ribosyltransferases, an update on function and nomenclature

Peer-reviewed
Open access
DOI
10.1111/febs.16142
Lüscher, B.; Ahel, I.; Altmeyer, M.; Ashworth, A.; Bai, P.; Chang, P.; Cohen, M.; Corda, D.; Dantzer...
Febs journal2021Publications information icon

Discovery of compounds inhibiting the ADP-ribosyltransferase activity of pertussis toxin

Peer-reviewed
Open access
DOI
10.1021/acsinfecdis.9b00412
Ashok, Yashwanth; Miettinen, Moona; de Oliveira, Danilo Kimio Hirabae; Tamirat, Mahlet Z.; Näreoja, ...
ACS infectious diseases2020Publications information icon

Analogs of TIQ-A as inhibitors of human mono-ADP-ribosylating PARPs

Peer-reviewed
Open access
DOI
10.1016/j.bmc.2021.116511
Maksimainen, Mirko M.; Murthy, Sudarshan; Sowa, Sven T.; Galera Prat, Albert; Rolina, Elena; Heiskan...
Bioorganic and medicinal chemistry2021Publications information icon

Assay technologies facilitating drug discovery for ADP-ribosyl writers, readers and erasers

Peer-reviewed
Open access
DOI
10.1002/bies.202100240
Glumoff, Tuomo; Sowa, Sven T.; Lehtiö, Lari
Bioessays2022Publications information icon

Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening

Peer-reviewed
Open access
DOI
10.1016/j.antiviral.2022.105344
Roy, Anu; Alhammad, Yousef M.; McDonald, Peter; Johnson, David K.; Zhuo, Junlin; Wazir, Sarah; Ferra...
Antiviral research2022

Small-molecule screening assay for mono-adp-ribosyltransferases

Peer-reviewed
Open access
DOI
10.1007/978-1-4939-8588-3_16
2018

ADP-ribosylation in DNA repair – structural studies of human ADP-ribosyltransferase 2

2018

The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling

Peer-reviewed
Open access
DOI
10.1016/j.jbc.2021.101041
2021

Biochemical and structural studies of E3 ubiquitin ligase DTX3L : a protein at a crossroads of ubiquitination and ADP-ribosylation

2023

Inhibition of the Poly-ADP-Ribosylation activity of Tankyrases: Role in obesity, diabetes, and kidney injury

Open access
2021

ADP-ribosyltransferases, an update on function and nomenclature

Peer-reviewed
Open access
DOI
10.1111/febs.16142
2021

Discovery of compounds inhibiting the ADP-ribosyltransferase activity of pertussis toxin

Peer-reviewed
Open access
DOI
10.1021/acsinfecdis.9b00412
2020

Analogs of TIQ-A as inhibitors of human mono-ADP-ribosylating PARPs

Peer-reviewed
Open access
DOI
10.1016/j.bmc.2021.116511
2021

Assay technologies facilitating drug discovery for ADP-ribosyl writers, readers and erasers

Peer-reviewed
Open access
DOI
10.1002/bies.202100240
2022

Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening

Peer-reviewed
Open access
DOI
10.1016/j.antiviral.2022.105344
2022